44.40840 USD
0.8312
1.84%
Last update Dec 18, 3:43 PM GMT
Market closed
Day range
42.72770
46.47130
Previous close
45.23960
Open
44.75
Access this stock data via API
Subscribe
Nektar Therapeutics Inc.
44.41
0.83
1.84%

Financials

Income statement

Fundamentals currency is CAD
Fiscal date Sep 2022 Jun 2022 Mar 2022 Dec 2021
Total reported revenue 133.5M 199.7M 131.3M 104.1M
Cost of revenue 44.4M 38.5M 32.8M 29.5M
Gross profit 89.0M 161.2M 98.5M 74.6M
Operating expense
Research & development
Selling general and admin 14.8M 15.0M 13.0M 12.4M
Other operating expenses 12.9M 13.0M 11.6M 10.6M
Operating income 61.3M 133.2M 73.9M 51.6M
Non operating interest income
Income
Expense 4.8M 6.0M 5.9M 6.0M
Other income expense 84.2M -5.4M -70.2M 22.4M
Pretax income 140.5M 121.5M -2.5M 67.8M
Tax provision 34.8M 32.8M -1.1M 16.9M
Net income 105.7M 88.7M -1.4M 50.9M
Basic EPS 0.7 0.6 0.0
Diluted EPS 0.7 0.6 0.0
Basic average shares 152.4M 152.6M 151.6M
Diluted average shares 162.6M 161.3M 151.6M
EBITDA 85.6M 158.8M 98.5M 73.9M
Net income from continuing op. 105.7M 88.7M -1.4M 50.9M
Minority interests
Preferred stock dividends
Access the full /income_statement historical dataset via the API — starting from the Pro plan.
Market closed

Exchange is currently closed
Pre-market opens in 11 hours 2 minutes

20:12
00:00
08:00
16:30
23:59

Trading Hours (Monday - Friday):

Pre-market
07:15 - 08:00
Main market
08:00 - 16:30
Post-market
16:30 - 17:15
All times are displayed in the Europe/London timezone (GMT, UTC+00:00).